How we’re using AI tools to improve psychedelic-drug research

Félix Schoeller's team has developed an AI chatbot to train facilitators for psychedelic drug research studies. This innovation aims to improve the quality and consistency of research into psychoactive drugs while ultimately benefiting public health outcomes.